Nuveen S&P 500 Buy-Write Income Fund

Nuveen S&P 500 Buy-Write Income Fund is a closed-ended equity indexed mutual fund launched by Nuveen Investments, Inc. It is co-managed by Nuveen Fund Advisors LLC and Gateway Investment Advisers, LLC. The fund invests in the public equity markets of the United States. It seeks to invest in stocks of companies operating across diversified sectors. The fund also invests through index call options. It seeks to replicate the performance of the S&P 500 Index by investing in proportion to their weighting in the index. The fund was formerly known as Nuveen Equity Premium Income Fund. Nuveen S&P 500 Buy-Write Income Fund was formed on July 23, 2004 and domiciled in the United States.

Nuveen S&P 500 Buy-Write Income Fund trades as BXMX on NYSE. The company is classified in Financial Services / Asset Management - Income and reports in USD.

The current profile places the business in Asset Management - Income. This section is intended to summarize the operating segments, products, geographies, and main revenue lines from official filings.

Latest available fiscal data shows $48.47M of revenue and $208.97M of net income.

Use this area for management strategy, capital allocation priorities, target markets, and measurable goals from the latest annual report or investor presentation.

The app now provides the structure, but exact strategic claims should come from official company documents before being treated as a finished investment thesis.

Nuveen S&P 500 Buy-Write Income Fund can be compared against peers such as DoubleLine Income Solutions Fund, Eaton Vance Tax-Advantaged Global Dividend Income Fund, Eaton Vance Tax-Managed Buy-Write Opportunities Fund, BlackRock Corporate High Yield Fund, Inc., Transamerica Capital Growth Fund, Nuveen Floating Rate Income Fund.

A complete thesis should compare growth, margins, balance-sheet risk, valuation multiples, and market position against direct competitors.

Current signals to investigate include market capitalization of $1.38B, beta of 0.80, and return on equity of +12.5%.

This section should be validated with evidence such as durable margins, brand strength, regulation, switching costs, cost advantage, distribution, or technology.

Key risks should include financial leverage, cyclicality, customer concentration, regulatory exposure, currency risk, and execution risk.

BXMX currently shows total debt of $25.02M and beta of 0.80. Missing data should be treated as a research gap, not as low risk.

Production-capacity detail is not available as structured data yet. For industrial, defense, semiconductor, or real-estate companies, this should be reviewed from annual reports and investor presentations.

No structured backlog field is available yet. If the company reports backlog, review the relevant filing section before adding it to the thesis.

Use this section for major contracts, product launches, construction projects, acquisitions, or strategic programs that can materially affect valuation.

Recent filings to review: SC 13G/A (2026-04-08 00:00:00), 25-NSE (2026-03-30 00:00:00), N-CEN (2026-03-16 00:00:00), N-CSR (2026-03-06 00:00:00).

Customer concentration is not available as structured data here. Add it from official filings when a company discloses material customers or revenue concentration.

Supplier concentration and critical supply-chain dependencies are not available as structured data here. This should be researched from annual reports and risk disclosures.

Company website: https://www.nuveen.com/CEF/Product/Overview.aspx?FundCode=BXMX

For US-listed stocks, verify the thesis against official filings, earnings call transcripts, and company investor relations materials.